An Asian regional analysis of cost-effectiveness of early irbesartan treatment versus conventional antihypertensive, late amlodipine, and late irbesartan treatments in patients with type 2 diabetes, hypertension, and nephropathy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples